AIM Vaccine Co., Ltd. (HKG:6660)
Hong Kong · Delayed Price · Currency is HKD 3.000
+0.150 (5.26%)
At close: Mar 27, 2026
AIM Vaccine Market Cap
AIM Vaccine has a market cap or net worth of 3.68 billion as of March 27, 2026. Its market cap has decreased by -43.21% in one year.
Market Cap
3.68B
Enterprise Value
5.45B
Revenue
1.38B
Ranking
n/a
PE Ratio
n/a
Stock Price
3.00
Market Cap Chart
Since October 6, 2022, AIM Vaccine's market cap has decreased from 20.15B to 3.68B, a decrease of -81.74%. That is a compound annual growth rate of -38.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 26, 2026 | 3.50B | -11.21% |
| Dec 31, 2025 | 3.94B | -47.05% |
| Dec 31, 2024 | 7.44B | -21.78% |
| Dec 29, 2023 | 9.51B | -67.02% |
| Dec 30, 2022 | 28.82B | 43.02% |
| Oct 6, 2022 | 20.15B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Viva Biotech Holdings | 4.12B |
| BioDlink International Company | 4.11B |
| Qyuns Therapeutics | 4.04B |
| Shandong Boan Biotechnology | 4.00B |
| TYK Medicines | 3.87B |
| Mirxes Holding Company | 3.75B |
| Clover Biopharmaceuticals | 3.41B |
| Medtide | 3.18B |